KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $13,170,000 | -43.6% | 2,263,006 | 0.0% | 9.51% | -48.4% |
Q2 2021 | $23,354,000 | -1.9% | 2,263,006 | 0.0% | 18.44% | +12.2% |
Q1 2021 | $23,806,000 | -32.0% | 2,263,006 | 0.0% | 16.44% | -28.6% |
Q4 2020 | $35,031,000 | -19.2% | 2,263,006 | 0.0% | 23.03% | -32.7% |
Q4 2019 | $43,381,000 | – | 2,263,006 | – | 34.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |